Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1443-1451

  Sampaio, L H ^a   Sousa, A L M ^a   Barcelos, M C ^a   Reed, S G ^b   Stefani, M M A ^a   Duthie, M S ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BIOLOGICAL MARKER; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 31; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; BORDERLINE LEPROSY; BRAZIL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTACT EXAMINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; LEPROMATOUS LEPROSY; MALE; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; PATHOGENESIS; PAUCIBACILLARY LEPROSY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RISK ASSESSMENT; TUBERCULOID LEPROSY; ADOLESCENT; BLOOD; FAMILY HEALTH; IMMUNOLOGY; LEPROSY; MIDDLE AGED; SECRETION;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; BRAZIL; CYTOKINES; FAMILY HEALTH; FEMALE; HUMANS; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; YOUNG ADULT;

EID: 84865583725     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1462-0     Document Type: Article

References (44)

1. Scollard DM (2008) The biology of nerve injury in leprosy. Lepr Rev 79(3):242-253
2. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19(2):338-381
3. World Health Organization (WHO) (2009) Global leprosy situation, 2009. Wkly Epidemiol Rec 84(33):333-340
4. Duthie MS, Goto W, Ireton GC, Reece ST, Cardoso LP, Martelli CM, Stefani MM, Nakatani M, de Jesus RC, Netto EM, Balagon MV, Tan E, Gelber RH, Maeda Y, Makino M, Hoft D, Reed SG (2007) Use of protein antigens for early serological diagnosis of leprosy. Clin Vaccine Immunol 14(11):1400-1408
5. Duthie MS, Ireton GC, Kanaujia GV, Goto W, Liang H, Bhatia A, Busceti JM, Macdonald M, Neupane KD, Ranjit C, Sapkota BR, Balagon M, Esfandiari J, Carter D, Reed SG (2008) Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis. Clin Vaccine Immunol 15(10):1590-1597
6. Oskam L, Slim E, Bührer-Sékula S (2003) Serology: Recent developments, strengths, limitations and prospects: A state of the art overview. Lepr Rev 74(3):196-205
7. Dockrell HM, Black GF, Weir RE, Fine PE (2000) Whole blood assays for interferon-gamma: Practicalities and potential for use as diagnostic tests in the field. Lepr Rev 71(Suppl): S60-S62
8. Aráoz R, Honoré N, Banu S, Demangel C, Cissoko Y, Arama C, Uddin MK, Hadi SK, Monot M, Cho SN, Ji B, Brennan PJ, Sow S, Cole ST (2006) Towards an immunodiagnostic test for leprosy. Microbes Infect 8(8):2270-2276
9. Dockrell HM, Brahmbhatt S, Robertson BD, Britton S, Fruth U, Gebre N, Hunegnaw M, Hussain R, Manadhar R, Murrillo L, Pessolani MC, Roche P, Salgado JL, Sampaio E, Shahid F, Thole JE, Young DB (2000) Diagnostic assays for leprosy based on Tcell epitopes. Lepr Rev 71(Suppl):S55-S58; discussion S58-S59
10. Keeler E, Perkins MD, Small P, Hanson C, Reed S, Cunningham J, Aledort JE, Hillborne L, Rafael ME, Girosi F, Dye C (2006) Reducing the global burden of tuberculosis: The contribution of improved diagnostics. Nature 444(Suppl 1):49-57
11. Nyendak MR, Lewinsohn DA, Lewinsohn DM (2009) New diagnostic methods for tuberculosis. Curr Opin Infect Dis 22 (2):174-182
12. Connell TG, Rangaka MX, Curtis N, Wilkinson RJ (2006) QuantiFERON-TB Gold: State of the art for the diagnosis of tuberculosis infection? Expert Rev Mol Diagn 6(5):663-677
13. Menzies D, Pai M, Comstock G (2007) Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 146(5):340-354
14. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cellbased assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 149(3):177-184
15. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M (2009) Withinsubject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: A systematic review. PLoS One 4(12):e8517
16. Mazurek GH, Villarino ME (2003) Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 52(RR-2):15-18
17. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honoré N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG (2001) Massive gene decay in the leprosy bacillus. Nature 409 (6823):1007-1011
18. Spencer JS, Dockrell HM, Kim HJ, Marques MA, Williams DL, Martins MV, Martins ML, Lima MC, Sarno EN, Pereira GM, Matos H, Fonseca LS, Sampaio EP, Ottenhoff TH, Geluk A, Cho SN, Stoker NG, Cole ST, Brennan PJ, Pessolani MC (2005) Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol 175(12):7930-7938
19. Geluk A, Klein MR, Franken KL, van Meijgaarden KE, Wieles B, Pereira KC, Bührer-Sékula S, Klatser PR, Brennan PJ, Spencer JS, Williams DL, Pessolani MC, Sampaio EP, Ottenhoff TH (2005) Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection. Infect Immun 73(9):5636-5644
20. Geluk A, Spencer JS, Bobosha K, Pessolani MC, Pereira GM, Banu S, Honoré N, Reece ST, MacDonald M, Sapkota BR, Ranjit C, Franken KL, Zewdie M, Aseffa A, Hussain R, Stefani MM, Cho SN, Oskam L, Brennan PJ, Dockrell HM; IDEAL Consortium (2009) From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin Vaccine Immunol 16 (3):352-359
21. Aráoz R, Honoré N, Cho S, KimJP, Cho SN,Monot M, Demangel C, Brennan PJ, Cole ST (2006) Antigen discovery: A postgenomic approach to leprosy diagnosis. Infect Immun 74(1):175-182
22. Duthie MS, Goto W, Ireton GC, Reece ST, Sampaio LH, Grassi AB, Sousa AL, Martelli CM, Stefani MM, Reed SG (2008) Antigen-specific T-cell responses of leprosy patients. Clin Vaccine Immunol 15(11):1659-1665
23. Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, Duthie MS (2011) Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC Infect Dis 11(1):26
24. Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH (2008) Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Clin Vaccine Immunol 15(3):522-533
25. Stefani MM, Guerra JG, Sousa AL, Costa MB, Oliveira ML,Martelli CT, ScollardDM(2009) Potential plasmamarkers of Type 1 and Type 2 leprosy reactions: A preliminary report. BMC Infect Dis 9(1):75
26. Geluk A, van der Ploeg-van Schip JJ, van Meijgaarden KE, Commandeur S, Drijfhout JW, Benckhuijsen WE, Franken KL, Naafs B, Ottenhoff TH (2010) Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in wholeblood assays. Clin Vaccine Immunol 17(6):993-1004
27. Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity. a five-group system. Int J Lepr Other Mycobact Dis 34(3):255-273
28. Fine PE, Sterne JA, Pönnighaus JM, Bliss L, Saui J, Chihana A, Munthali M, Warndorff DK (1997) Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol 146(1):91-102
29. Bakker MI, Hatta M, Kwenang A, Van Mosseveld P, Faber WR, Klatser PR, Oskam L (2006) Risk factors for developing leprosy -a population-based cohort study in Indonesia. Lepr Rev 77(1):48-61
30. Goulart IM, Bernardes Souza DO, Marques CR, Pimenta VL, Gonçalves MA, Goulart LR (2008) Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts. Clin Vaccine Immunol 15(1):101-105
31. De Rojas V, Hernández O, Gil R (1994) Some factors influencing delay in leprosy diagnosis. Bull Pan Am Health Organ 28(2):156-162
32. Chen XS, Li WZ, Jiang C, Ye GY (2000) Leprosy in China: Delay in the detection of cases. Ann Trop Med Parasitol 94(2):181-188
33. Deps PD, Guedes BV, Bucker Filho J, Andreatta MK, Marcari RS, Rodrigues LC (2006) Delay in the diagnosis of leprosy in the metropolitan region of Vitória, Brazil. Lepr Rev 77(1):41-47
34. Van Veen NH, Meima A, Richardus JH (2006) The relationship between detection delay and impairment in leprosy control: A comparison of patient cohorts from Bangladesh and Ethiopia. Lepr Rev 77(4):356-365
35. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 254 (5029):277-279
36. Sieling PA, Modlin RL (1994) Cytokine patterns at the site of mycobacterial infection. Immunobiology 191(4-5):378-387
37. Misra N, Murtaza A, Walker B, Narayan NP, Misra RS, Ramesh V, Singh S, Colston MJ, Nath I (1995) Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 86(1):97-103
38. Britton WJ, Hellqvist L, Garsia RJ, Basten A (1987) Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol 67(1):31-42
39. Molloy A, Gaudernack G, Levis WR, Cohn ZA, Kaplan G (1990) Suppression of T-cell proliferation by Mycobacterium leprae and its products: The role of lipopolysaccharide. Proc Natl Acad Sci USA 87(3):973-977
40. Teles RM, Krutzik SR, Ochoa MT, Oliveira RB, Sarno EN, Modlin RL (2010) Interleukin-4 regulates the expression of CD209 and subsequent uptake of Mycobacterium leprae by Schwann cells in human leprosy. Infect Immun 78(11):4634-4643
41. Mira MT, Alcaïs A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP, Nguyen TH, Nguyen NB, Pham XK, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Doré C, Gallant CJ, Lepage P, Verner A, Van De Vosse E, Hudson TJ, Abel L, Schurr E (2004) Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427(6975):636-640
42. da Silva SA, Mazini PS, Reis PG, Sell AM, Tsuneto LT, Peixoto PR, Visentainer JE (2009) HLA-DR and HLA-DQ alleles in patients from the south of Brazil: Markers for leprosy susceptibility and resistance. BMC Infect Dis 9:134
43. Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO (2011) Leprosy susceptibility: Genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol 6 (5):533-549
44. Liao W, Schones DE, Oh J, Cui Y, Cui K, Roh TY, Zhao K, Leonard WJ (2008) Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alphachain expression. Nat Immunol 9(11):1288-1296